Has Amada Mendoza received payments from drug or device companies?

Yes. Drug and device makers reported $2,774 in general payments to Amada Mendoza across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amada Mendoza did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amada Mendoza come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amada Mendoza

Women's Health · Norwalk, CANPI 1013059062

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 34.0% of the total. 2025 is the largest year on record at $1,364, 3.4 times the $401 reported in 2021. Among women's health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,774in general payments, 2019–2025

Across 101 payments — averaging $27.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$944
Sage Therapeutics, LLC$300
Organon$249
GSK$236
Shield Therapeutics Inc$203
Boehringer Ingelheim$156
plus $686 from 13 others

What the payments were for

Food & beverage$2,774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	21	$944
Sage Therapeutics, LLC	14	$300
Organon	16	$249
GSK	9	$236
Shield Therapeutics Inc	10	$203
Boehringer Ingelheim	3	$156
Merck	6	$120
Biogen	1	$114
Exact Sciences	3	$97
Bayer	3	$64
Sanofi Pasteur Inc.	3	$59
Supernus Pharmaceuticals, Inc.	2	$43
Hologic Sales And Service, LLC	2	$41
Amarin Pharma, Inc.	2	$38
Lilly USA, LLC	2	$33
Myovant Sciences Inc.	1	$25
Pfizer	1	$21
Phadia US Inc.	1	$17
Cranial Technologies, Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,774 in reported general payments places this provider in the 95th percentile of 480 women's health providers in California.

See all women's health providers in California →

Other women's health in Norwalk

Amy SantiagoNorwalk$2K
Barbara DehnMountain View$87K
Zaruhi HarutyunyanWest Hollywood$55K
Roberta MoradfarWest Hollywood$30K
Patricia GeraghtyWalnut Creek$26K
Katherine KetzStockton$26K
Debbie BarishBerkeley$16K
Raisa HowardEl Segundo$11K
Mary FesselWoodland$8K
Kay MorelandSanta Maria$6K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →